MyHub
Specchio-Covid19

Specchio-Covid19

From spring 2020, in response to the COVID-19 pandemic, the Unit of Population Epidemiology (UEP) has set up several seroprevalence studies in the canton of Geneva (SEROCoV-POP, SEROCoV-WORK, Specchio-COVID19) to determine the proportion of the Geneva population who have developed antibodies against SARS-CoV-2 (the virus responsible for COVID-19), following infection or vaccination.

What does the Specchio-COVID19 study involve?

  • An initial questionnaire to be completed at the time of inclusion
  • A serological test by blood sampling at the time of inclusion
  • Follow-up using online questionnaires
  • Follow-up with serological tests as required by the study

What are the aims of the Specchio-COVID19 study?

To determine the serological and immune status of the population

The Specchio-COVID19 study makes it possible to :

  • determine the proportion of the population living in Geneva who have developed antibodies against SARS-CoV-2, whether as a result of infection or vaccination
  • improve our knowledge of the level and duration of protection provided by antibodies against new infections with SARS-CoV-2 and its various variants

To study the health, social and economic implications of the COVID-19 pandemic.

The data collected will also be used to

  • gain a better understanding of the short- and long-term impact of the pandemic on the physical and mental health, working life, social life and family life of the population of the canton of Geneva
  • assess how the population is adapting its behavior and lifestyles (diet, physical exercise, alcohol and tobacco consumption, etc.) to the health situation
  • highlight the persistence of COVID-19 symptoms several weeks or even months after infection (post-COVID).

Guiding public action to deal with the COVID-19 pandemic

In addition to producing precise scientific data, the results obtained in the Specchio-COVID19 study are regularly brought to the attention of public health players and decision-makers, in order to guide public action in managing the COVID-19 pandemic and its consequences.

What are the benefits of the study for the participants?

The participants form a community of volunteers who:

  • actively contributes to advancing research on COVID-19
  • receives regular, reliable information and study results via the "News" and "Research" pages and a quarterly newsletter
  • can interact with our research teams (emails, webinars, etc.)
  • take part in a collective effort for the benefit of the whole population

Orienting public action to deal with the COVID-19 pandemic

The Specchio-COVID19 study is part of the Swiss national research program Corona Immunitas, coordinated by the Swiss School of Public Health (SSPH+), which aims to collect reliable and comparable epidemiological data on a national scale.

Find out more Publications

What studies are we conducting?

Specchio

Icon

The Specchio (“mirror” in Italian) study aims to better understand and monitor the health status of the Geneva population over time. 

Read more

Bus Santé

Icon

Bus Santé was launched in 1992 and is a cross-sectional study conducted each year with a thousand new participants.

Read more

SEROCoV-KIDS

Icon

The aim of the SEROCOV-KIDS study is to assess the impact of the COVID-19 pandemic on the health and development of children and adolescents in the Canton of Geneva.

Read more

SEROCoV-Schools

Icon

The aim of this longitudinal study (i.e. including monitoring over time) was to assess the prevalence and transmission routes of COVID-19 in schools and childcare facilities.

Read more